ホーム>>Signaling Pathways>> Others>> Environmental Toxicology>>Boscalid

Boscalid

カタログ番号GC46943

広範囲スペクトルのカルボキサミド系殺菌剤

Products are for research use only. Not for human use. We do not sell to patients.

Boscalid 化学構造

Cas No.: 188425-85-6

サイズ 価格 在庫数 個数
50 mg
$60.00
在庫あり
100 mg
$103.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Boscalid is a broad-spectrum carboxamide fungicide that inhibits fungal respiration by binding to the ubiquinone site of mitochondrial complex II/succinate dehydrogenase.1 It suppresses mycelial growth of S. minor by 87 to 100% and of S. sclerotiorum by 77 to 100% when used at a concentration of 1 µg/ml.2 In field studies, boscalid applied at 5.6 µg/cm2 provides 55.5 and 30.4% disease control for lettuce drop caused by S. minor and S. sclerotiorum, respectively. It decreases cell viability of mouse primary cortical neurons following long-term exposure but is not cytotoxic (LC50 = >100 µM for acute and continuous exposure). Formulations containing boscalid have been used in agriculture to prevent fungal growth on crops.

1.Wang, Y., Duan, Y., Wang, J., et al.A new point mutation in the iron-sulfur subunit of succinate dehydrogenase confers resistance to boscalid in Sclerotinia sclerotiorumMol. Plant Pathol.16(7)653-661(2015) 2.Matheron, M.E., and Porchas, M.Activity of boscalid, fenhexamid, fluazinam, fludioxonil, and vinclozolin on growth of Sclerotinia minor and S. sclerotiorum and development of lettuce dropPlant Dis.88(6)665-668(2004)

レビュー

Review for Boscalid

Average Rating: 5 ★★★★★ (Based on Reviews and 24 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Boscalid

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.